Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Multiple Sclerosis - Relapsing Remitting
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 60 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03535298
- Collaborators
- University of Nottingham
- Investigators
- Principal Investigator: Daniel Ontaneda, MD, MSc The Cleveland Clinic Principal Investigator: Nikos Evangelou, MD, DPhil University of Nottingham